Logo

High Throughput Genomics Sells ArrayPlate System to ProSkelia

Oct 21, 2003

NEW YORK, Oct. 21 (GenomeWeb News) - High Throughput Genomics today said that ProSkelia would use its ArrayPlate high-throughput screening technology in one of its drug discovery programs.

The ArrayPlate contains a generic Universal Array in each well of a standard 96-well microplate to simultaneously measure up to 100 DNA, RNA, or protein molecules, acording to High Throughput Genomics. Each of the five-element ArrayPlate kits ProSkelia purchased includes four target genes and one control gene.

The company did not provide financial terms of the agreement.

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.